EXOSC2 and COVID-19: After Bonferroni multiple testing correction, only EXOSC2 expression was significantly associated with COVID-19 risk (Table S1 and Fig 1B); higher expression of EXOSC2 was associated with higher risk of clinical COVID-19 (Z = +4.32, P = 1.5 × 10−5).